7R6H
RHCC in complex with o-carborane
Summary for 7R6H
Entry DOI | 10.2210/pdb7r6h/pdb |
Descriptor | Tetrabrachion, ortho-carborane (3 entities in total) |
Functional Keywords | right-handed coiled coil, carborane, nanotube, transport protein |
Biological source | Staphylothermus marinus |
Total number of polymer chains | 4 |
Total formula weight | 23991.27 |
Authors | Heide, F.,McDougall, M.,Stetefeld, J. (deposition date: 2021-06-22, release date: 2021-07-07, Last modification date: 2023-10-18) |
Primary citation | Heide, F.,McDougall, M.,Harder-Viddal, C.,Roshko, R.,Davidson, D.,Wu, J.,Aprosoff, C.,Moya-Torres, A.,Lin, F.,Stetefeld, J. Boron rich nanotube drug carrier system is suited for boron neutron capture therapy. Sci Rep, 11:15520-15520, 2021 Cited by PubMed Abstract: Boron neutron capture therapy (BNCT) is a two-step therapeutic process that utilizes Boron-10 in combination with low energy neutrons to effectively eliminate targeted cells. This therapy is primarily used for difficult to treat head and neck carcinomas; recent advances have expanded this method to cover a broader range of carcinomas. However, it still remains an unconventional therapy where one of the barriers for widespread adoption is the adequate delivery of Boron-10 to target cells. In an effort to address this issue, we examined a unique nanoparticle drug delivery system based on a highly stable and modular proteinaceous nanotube. Initially, we confirmed and structurally analyzed ortho-carborane binding into the cavities of the nanotube. The high ratio of Boron to proteinaceous mass and excellent thermal stability suggest the nanotube system as a suitable candidate for drug delivery into cancer cells. The full physicochemical characterization of the nanotube then allowed for further mechanistic molecular dynamic studies of the ortho-carborane uptake and calculations of corresponding energy profiles. Visualization of the binding event highlighted the protein dynamics and the importance of the interhelical channel formation to allow movement of the boron cluster into the nanotube. Additionally, cell assays showed that the nanotube can penetrate outer membranes of cancer cells followed by localization around the cells' nuclei. This work uses an integrative approach combining experimental data from structural, molecular dynamics simulations and biological experiments to thoroughly present an alternative drug delivery device for BNCT which offers additional benefits over current delivery methods. PubMed: 34330984DOI: 10.1038/s41598-021-95044-0 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.2 Å) |
Structure validation
Download full validation report